Cholic Acid for Hepatic Steatosis in Lipodystrophy
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of cholic acid therapy in treating lipodystrophy patients
with hepatic steatosis. This is a randomized, double-blind, placebo-controlled cross-over
study.